Publications by authors named "Si Tamura"

Claim this Profile
H
Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
Akira Ainai, Elly van Riet, Ryo Ito, Kazuyuki Ikeda, Kyosuke Senchi, Shin-Ichi Tamura

Microbiol Immunol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
Yoshihiko Terauchi, Kaori Sano, Akira Ainai, Shinji Saito, Yuki Taga, Shin-Ichi Tamura

Hum Vaccin Immunother· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate.
Akira Ainai, Tadaki Suzuki, Shin-Ichi Tamura, Hideki Hasegawa

Viral Immunol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Shin-Ichi Tamura, Akira Ainai, Tadaki Suzuki, Takeshi Kurata, Hideki Hasegawa

Jpn J Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graphene/nitrogen-functionalized graphene quantum dot hybrid broadband photodetectors with a buffer layer of boron nitride nanosheets.
Hiroyuki Tetsuka, Akihiro Nagoya, Shin-Ichi Tamura

Nanoscale· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults.
Akira Ainai, Shin-Ichi Tamura, Tadaki Suzuki, Elly van Riet, Ryo Ito

Hum Vaccin Immunother· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the cross-reactive anti-influenza neutralizing activity of polymeric and monomeric IgA monoclonal antibodies.
Takeshi Tanimoto, Ahmad M Haredy, Nobuyuki Takenaka, Shin-Ichi Tamura, Yoshinobu Okuno

Viral Immunol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia.
Hiroyuki Ishida, Kosuke Imai, Kenichi Honma, Shin-Ichi Tamura, Toshihiko Imamura

Eur J Pediatr· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine.
Akira Ainai, Shin-Ichi Tamura, Tadaki Suzuki, Ryo Ito, Hideki Asanuma

J Med Virol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine.
Akira Ainai, Takeshi Ichinohe, Shin-Ichi Tamura, Takeshi Kurata, Tetsutaro Sata

J Med Virol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
Takeshi Ichinohe, Akira Ainai, Tomoyuki Nakamura, Yukihito Akiyama, Jun-Ichi Maeyama, Shin-Ichi Tamura

J Med Virol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses.
Hideki Hasegawa, Takeshi Ichinohe, Akira Ainai, Shin-Ichi Tamura, Takeshi Kurata

Ther Clin Risk Manag· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza PR8 HA-specific Fab fragments produced by phage display methods.
Hideki Asanuma, Ayano Matsumoto-Takasaki, Yujiro Suzuki, Shin-Ichi Tamura, Tetsutaro Sata

Biochem Biophys Res Commun· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
Takeshi Ichinohe, Shin-Ichi Tamura, Akira Kawaguchi, Ai Ninomiya, Masaki Imai, Shigeyuki Itamura

J Infect Dis· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.
Hideki Asanuma, Kohtaro Fujihashi, Takashi Miyakoshi, Tomoki Yoshikawa, Yoko Fujita-Yamaguchi, Shin-Ichi Tamura

Vaccine· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
Yasuko Asahi-Ozaki, Shigeyuki Itamura, Takeshi Ichinohe, Peter Strong, Shin-Ichi Tamura

Microbes Infect· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Takeshi Ichinohe, Izumi Watanabe, Satoshi Ito, Hideki Fujii, Masami Moriyama, Shin-Ichi Tamura

J Virol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
Hideki Hasegawa, Takeshi Ichinohe, Peter Strong, Izumi Watanabe, Satoshi Ito, Shin-Ichi Tamura

J Med Virol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.
Yasuko Asahi-Ozaki, Tomoki Yoshikawa, Yoichiro Iwakura, Yujiro Suzuki, Shin-Ichi Tamura

J Med Virol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice.
Tomoki Yoshikawa, Keiko Matsuo, Kazutoshi Matsuo, Yujiro Suzuki, Akio Nomoto, Shin-Ichi Tamura

J Gen Virol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.
Tomoki Yoshikawa, Yujiro Suzuki, Akio Nomoto, Tetutaro Sata, Takeshi Kurata, Shin ichi Tamura

Vaccine· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia.
Hajime Nakamura, Shin ichi Tamura, Izumi Watanabe, Takuya Iwasaki, Junji Yodoi

Immunol Lett· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza A virus-induced mortality in mice.
Keiko Nohara, Hiroyuki Izumi, Shin ichi Tamura, Ryoichi Nagata, Chiharu Tohyama

Toxicology· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination.
Hideki Hasegawa, Shin etsu Kadowaki, Izumi Watanabe, Hiroshi Aizawa, Hidehiro Takahashi, Shin ichi Tamura

Vaccine· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
S I Tamura, T Kurata

Jpn J Infect Dis· June 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis